Regulation of Human Alveolar Macrophage Inflammatory Cytokine Production by Interleukin-10

Alveolar macrophages are the primary source of inflammatory cytokine production in the lung. Both site-specific and differentiation-specific factors play a role in cytokine production, and regulation of this activity in alveolar macrophages is distinctly different from that of circulating blood mono...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology and immunopathology 1996-09, Vol.80 (3), p.321-324
Hauptverfasser: Thomassen, Mary Jane, Divis, Lisa T., Fisher, Charles J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 324
container_issue 3
container_start_page 321
container_title Clinical immunology and immunopathology
container_volume 80
creator Thomassen, Mary Jane
Divis, Lisa T.
Fisher, Charles J.
description Alveolar macrophages are the primary source of inflammatory cytokine production in the lung. Both site-specific and differentiation-specific factors play a role in cytokine production, and regulation of this activity in alveolar macrophages is distinctly different from that of circulating blood monocytes. Interleukin-10 (IL-10) inhibits the production of inflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin-1 (IL-1), interleukin-6 (IL-6), and interleukin-8 (IL-8)] and enhances production of interleukin-1-receptor antagonist (IL-1ra) from endotoxin-stimulated human monocytes, but the effect of IL-10 on such activity in alveolar macrophages is unknown. This study was undertaken to determine the effect of recombinant IL-10 on endotoxin-stimulated cytokine production by human alveolar macrophages. TNF, IL-1, IL-6, and IL-8 secretions were significantly (P< 0.05) stimulated by endotoxin [lipopolysaccharide (LPS)] and were all significantly (P< 0.05) inhibited (median inhibition = 43%) by IL-10 (10 ng/ml). In contrast, IL-1ra was not stimulated by LPS and basal levels were not affected by IL-10. LPS also did not significantly elevate alveolar macrophage IL-10 secretion (
doi_str_mv 10.1006/clin.1996.0130
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78339912</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090122996901300</els_id><sourcerecordid>78339912</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-e6b162928e1c90b1c782b404c30c4dfb4c46fd1b78bf3079529033fba4b8a5c73</originalsourceid><addsrcrecordid>eNqFkUGP1CAYhonRrOPq1ZtJD8ZbRz5gWjhuJupuskZj9OKFAP1YUVpGaDeZfy91JnszniB5n_cDHgh5CXQLlHZvXQzTFpTqthQ4fUQ2QBVtGRfwmGzougfG1FPyrJSftBYE7S_IhZQAdCc25PsXvFuimUOamuSb62U0U3MV7zFFk5uPxuV0-GHusLmZfDTjaOaUj83-OKdfYcLmc07D4v627bEyM-aIS41aoM_JE29iwRfn9ZJ8e__u6_66vf304WZ_dds6rtTcYmehY4pJBKeoBddLZgUVjlMnBm-FE50fwPbSek57tWOKcu6tEVaanev5JXlzmnvI6feCZdZjKA5jNBOmpehe8noQsP-C0AFI1qkKbk9gfX0pGb0-5DCafNRA9Wpdr9b1al2v1mvh1XnyYkccHvCz5pq_PuemOBN9NpML5QHjrP5TzysmTxhWXfcBsy4u4ORwCBndrIcU_nWDPxr_nYY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16118269</pqid></control><display><type>article</type><title>Regulation of Human Alveolar Macrophage Inflammatory Cytokine Production by Interleukin-10</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Thomassen, Mary Jane ; Divis, Lisa T. ; Fisher, Charles J.</creator><creatorcontrib>Thomassen, Mary Jane ; Divis, Lisa T. ; Fisher, Charles J.</creatorcontrib><description>Alveolar macrophages are the primary source of inflammatory cytokine production in the lung. Both site-specific and differentiation-specific factors play a role in cytokine production, and regulation of this activity in alveolar macrophages is distinctly different from that of circulating blood monocytes. Interleukin-10 (IL-10) inhibits the production of inflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin-1 (IL-1), interleukin-6 (IL-6), and interleukin-8 (IL-8)] and enhances production of interleukin-1-receptor antagonist (IL-1ra) from endotoxin-stimulated human monocytes, but the effect of IL-10 on such activity in alveolar macrophages is unknown. This study was undertaken to determine the effect of recombinant IL-10 on endotoxin-stimulated cytokine production by human alveolar macrophages. TNF, IL-1, IL-6, and IL-8 secretions were significantly (P&lt; 0.05) stimulated by endotoxin [lipopolysaccharide (LPS)] and were all significantly (P&lt; 0.05) inhibited (median inhibition = 43%) by IL-10 (10 ng/ml). In contrast, IL-1ra was not stimulated by LPS and basal levels were not affected by IL-10. LPS also did not significantly elevate alveolar macrophage IL-10 secretion (&lt;100 pg/ml) and basal levels were undetectable (&lt;15 pg/ml). This potent inhibitory activity of IL-10 on inflammatory cytokine production by human alveolar macrophages suggests that exogenous IL-10 may be useful in treatment of inflammatory lung diseases such as adult respiratory distress syndrome.</description><identifier>ISSN: 0090-1229</identifier><identifier>EISSN: 1090-2341</identifier><identifier>DOI: 10.1006/clin.1996.0130</identifier><identifier>PMID: 8811054</identifier><identifier>CODEN: CLIIAT</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Analysis of the immune response. Humoral and cellular immunity ; Biological and medical sciences ; Cytokines - biosynthesis ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Humans ; Immunobiology ; Inflammation - metabolism ; Interleukin-10 - biosynthesis ; Interleukin-10 - metabolism ; Interleukin-10 - pharmacology ; Interleukin-2 - biosynthesis ; Lymphokines, interleukins ( function, expression) ; Macrophages, Alveolar - drug effects ; Macrophages, Alveolar - metabolism ; Regulatory factors and their cellular receptors ; Tumor Necrosis Factor-alpha - biosynthesis</subject><ispartof>Clinical immunology and immunopathology, 1996-09, Vol.80 (3), p.321-324</ispartof><rights>1996 Academic Press</rights><rights>1996 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-e6b162928e1c90b1c782b404c30c4dfb4c46fd1b78bf3079529033fba4b8a5c73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3209073$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8811054$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thomassen, Mary Jane</creatorcontrib><creatorcontrib>Divis, Lisa T.</creatorcontrib><creatorcontrib>Fisher, Charles J.</creatorcontrib><title>Regulation of Human Alveolar Macrophage Inflammatory Cytokine Production by Interleukin-10</title><title>Clinical immunology and immunopathology</title><addtitle>Clin Immunol Immunopathol</addtitle><description>Alveolar macrophages are the primary source of inflammatory cytokine production in the lung. Both site-specific and differentiation-specific factors play a role in cytokine production, and regulation of this activity in alveolar macrophages is distinctly different from that of circulating blood monocytes. Interleukin-10 (IL-10) inhibits the production of inflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin-1 (IL-1), interleukin-6 (IL-6), and interleukin-8 (IL-8)] and enhances production of interleukin-1-receptor antagonist (IL-1ra) from endotoxin-stimulated human monocytes, but the effect of IL-10 on such activity in alveolar macrophages is unknown. This study was undertaken to determine the effect of recombinant IL-10 on endotoxin-stimulated cytokine production by human alveolar macrophages. TNF, IL-1, IL-6, and IL-8 secretions were significantly (P&lt; 0.05) stimulated by endotoxin [lipopolysaccharide (LPS)] and were all significantly (P&lt; 0.05) inhibited (median inhibition = 43%) by IL-10 (10 ng/ml). In contrast, IL-1ra was not stimulated by LPS and basal levels were not affected by IL-10. LPS also did not significantly elevate alveolar macrophage IL-10 secretion (&lt;100 pg/ml) and basal levels were undetectable (&lt;15 pg/ml). This potent inhibitory activity of IL-10 on inflammatory cytokine production by human alveolar macrophages suggests that exogenous IL-10 may be useful in treatment of inflammatory lung diseases such as adult respiratory distress syndrome.</description><subject>Analysis of the immune response. Humoral and cellular immunity</subject><subject>Biological and medical sciences</subject><subject>Cytokines - biosynthesis</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Humans</subject><subject>Immunobiology</subject><subject>Inflammation - metabolism</subject><subject>Interleukin-10 - biosynthesis</subject><subject>Interleukin-10 - metabolism</subject><subject>Interleukin-10 - pharmacology</subject><subject>Interleukin-2 - biosynthesis</subject><subject>Lymphokines, interleukins ( function, expression)</subject><subject>Macrophages, Alveolar - drug effects</subject><subject>Macrophages, Alveolar - metabolism</subject><subject>Regulatory factors and their cellular receptors</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><issn>0090-1229</issn><issn>1090-2341</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUGP1CAYhonRrOPq1ZtJD8ZbRz5gWjhuJupuskZj9OKFAP1YUVpGaDeZfy91JnszniB5n_cDHgh5CXQLlHZvXQzTFpTqthQ4fUQ2QBVtGRfwmGzougfG1FPyrJSftBYE7S_IhZQAdCc25PsXvFuimUOamuSb62U0U3MV7zFFk5uPxuV0-GHusLmZfDTjaOaUj83-OKdfYcLmc07D4v627bEyM-aIS41aoM_JE29iwRfn9ZJ8e__u6_66vf304WZ_dds6rtTcYmehY4pJBKeoBddLZgUVjlMnBm-FE50fwPbSek57tWOKcu6tEVaanev5JXlzmnvI6feCZdZjKA5jNBOmpehe8noQsP-C0AFI1qkKbk9gfX0pGb0-5DCafNRA9Wpdr9b1al2v1mvh1XnyYkccHvCz5pq_PuemOBN9NpML5QHjrP5TzysmTxhWXfcBsy4u4ORwCBndrIcU_nWDPxr_nYY</recordid><startdate>19960901</startdate><enddate>19960901</enddate><creator>Thomassen, Mary Jane</creator><creator>Divis, Lisa T.</creator><creator>Fisher, Charles J.</creator><general>Elsevier Inc</general><general>Academic Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19960901</creationdate><title>Regulation of Human Alveolar Macrophage Inflammatory Cytokine Production by Interleukin-10</title><author>Thomassen, Mary Jane ; Divis, Lisa T. ; Fisher, Charles J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-e6b162928e1c90b1c782b404c30c4dfb4c46fd1b78bf3079529033fba4b8a5c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Analysis of the immune response. Humoral and cellular immunity</topic><topic>Biological and medical sciences</topic><topic>Cytokines - biosynthesis</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Humans</topic><topic>Immunobiology</topic><topic>Inflammation - metabolism</topic><topic>Interleukin-10 - biosynthesis</topic><topic>Interleukin-10 - metabolism</topic><topic>Interleukin-10 - pharmacology</topic><topic>Interleukin-2 - biosynthesis</topic><topic>Lymphokines, interleukins ( function, expression)</topic><topic>Macrophages, Alveolar - drug effects</topic><topic>Macrophages, Alveolar - metabolism</topic><topic>Regulatory factors and their cellular receptors</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><toplevel>online_resources</toplevel><creatorcontrib>Thomassen, Mary Jane</creatorcontrib><creatorcontrib>Divis, Lisa T.</creatorcontrib><creatorcontrib>Fisher, Charles J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical immunology and immunopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thomassen, Mary Jane</au><au>Divis, Lisa T.</au><au>Fisher, Charles J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of Human Alveolar Macrophage Inflammatory Cytokine Production by Interleukin-10</atitle><jtitle>Clinical immunology and immunopathology</jtitle><addtitle>Clin Immunol Immunopathol</addtitle><date>1996-09-01</date><risdate>1996</risdate><volume>80</volume><issue>3</issue><spage>321</spage><epage>324</epage><pages>321-324</pages><issn>0090-1229</issn><eissn>1090-2341</eissn><coden>CLIIAT</coden><abstract>Alveolar macrophages are the primary source of inflammatory cytokine production in the lung. Both site-specific and differentiation-specific factors play a role in cytokine production, and regulation of this activity in alveolar macrophages is distinctly different from that of circulating blood monocytes. Interleukin-10 (IL-10) inhibits the production of inflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin-1 (IL-1), interleukin-6 (IL-6), and interleukin-8 (IL-8)] and enhances production of interleukin-1-receptor antagonist (IL-1ra) from endotoxin-stimulated human monocytes, but the effect of IL-10 on such activity in alveolar macrophages is unknown. This study was undertaken to determine the effect of recombinant IL-10 on endotoxin-stimulated cytokine production by human alveolar macrophages. TNF, IL-1, IL-6, and IL-8 secretions were significantly (P&lt; 0.05) stimulated by endotoxin [lipopolysaccharide (LPS)] and were all significantly (P&lt; 0.05) inhibited (median inhibition = 43%) by IL-10 (10 ng/ml). In contrast, IL-1ra was not stimulated by LPS and basal levels were not affected by IL-10. LPS also did not significantly elevate alveolar macrophage IL-10 secretion (&lt;100 pg/ml) and basal levels were undetectable (&lt;15 pg/ml). This potent inhibitory activity of IL-10 on inflammatory cytokine production by human alveolar macrophages suggests that exogenous IL-10 may be useful in treatment of inflammatory lung diseases such as adult respiratory distress syndrome.</abstract><cop>San Diego, CA</cop><cop>New York, NY</cop><cop>Boston</cop><pub>Elsevier Inc</pub><pmid>8811054</pmid><doi>10.1006/clin.1996.0130</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-1229
ispartof Clinical immunology and immunopathology, 1996-09, Vol.80 (3), p.321-324
issn 0090-1229
1090-2341
language eng
recordid cdi_proquest_miscellaneous_78339912
source MEDLINE; Alma/SFX Local Collection
subjects Analysis of the immune response. Humoral and cellular immunity
Biological and medical sciences
Cytokines - biosynthesis
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Humans
Immunobiology
Inflammation - metabolism
Interleukin-10 - biosynthesis
Interleukin-10 - metabolism
Interleukin-10 - pharmacology
Interleukin-2 - biosynthesis
Lymphokines, interleukins ( function, expression)
Macrophages, Alveolar - drug effects
Macrophages, Alveolar - metabolism
Regulatory factors and their cellular receptors
Tumor Necrosis Factor-alpha - biosynthesis
title Regulation of Human Alveolar Macrophage Inflammatory Cytokine Production by Interleukin-10
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T14%3A17%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20Human%20Alveolar%20Macrophage%20Inflammatory%20Cytokine%20Production%20by%20Interleukin-10&rft.jtitle=Clinical%20immunology%20and%20immunopathology&rft.au=Thomassen,%20Mary%20Jane&rft.date=1996-09-01&rft.volume=80&rft.issue=3&rft.spage=321&rft.epage=324&rft.pages=321-324&rft.issn=0090-1229&rft.eissn=1090-2341&rft.coden=CLIIAT&rft_id=info:doi/10.1006/clin.1996.0130&rft_dat=%3Cproquest_cross%3E78339912%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16118269&rft_id=info:pmid/8811054&rft_els_id=S0090122996901300&rfr_iscdi=true